Implantica AG reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was EUR 0.207 million compared to EUR 0.115 million a year ago. Net loss was EUR 5.76 million compared to EUR 2.88 million a year ago.
For the six months, sales was EUR 0.405 million compared to EUR 0.197 million a year ago. Net loss was EUR 10.54 million compared to EUR 4.84 million a year ago.